ASAP and Allen Institute Join Forces to Unlock Insights Into Parkinson’s and Neurodegenerative Diseases
The Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative have teamed up in a groundbreaking effort to advance […]
Amphix Bio Achieves Major Milestone with Orphan Drug Designation for AMFX-200 in Spinal Cord Injury Treatment
Amphix Bio, an emerging leader in regenerative medicine, has announced a significant breakthrough: the U.S. FDA has granted orphan drug
Innovent Biologics’ IBI343 Shines in Nature Medicine: A Major Step Forward in Gastric Cancer Treatment
Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing and commercializing innovative therapies, has announced a significant milestone. The
Sarepta’s Bold New Chapter: Reshaping Strategy and Elevating ELEVIDYS for the Future
Sarepta Therapeutics, a pioneer in precision genetic medicines for rare diseases, is setting the stage for a transformative future. Riding
Favorable Government Support Boosts Orthopedic Devices Market Growth in Asia-Pacific
🏥 Rapid Expansion of the Medical Device Sector Asia-Pacific’s orthopedic device market medical industry is experiencing an unprecedented boom. From
Canada Orthopedic Market Shows Promising Trends in 2025
The global orthopedic device markett is witnessing transformative growth, fueled by technological advancements, an aging population, and rising demand for
Why Did North America Dominate the Generative AI in Life Science Market in 2024?
North America seized 42% of the generative AI in life science market share in 2024. But what fueled this dominance?
Acadia Pharmaceuticals Projects $14 Billion Annual Revenue with New R&D Leadership and Expanding Drug Pipeline
San Diego, CA, July 18, 2025 Acadia Pharmaceuticals, a leader in treatments for neurological and rare diseases, has unveiled an
Zimmer Biomet to Acquire Monogram Technologies in $177 Million Deal
Warsaw, IN, July 18, 2025 – Zimmer Biomet Holdings, Inc., a leading innovator in medical technology, has announced a definitive
ViiV Healthcare VOLITION Study Highlights Shift Towards Long-Acting HIV Injections
London, July 18, 2025 – ViiV Healthcare, a global leader in HIV-focused pharmaceutical innovation, unveiled data from its Phase 3b